Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice.

by Nanda Gruben, Marcela Aparicio Vergara, Niels J Kloosterhuis, Henk van der Molen, Stefan Stoelwinder, Sameh Youssef, Alain de Bruin, Dianne J Delsing, Jan Albert Kuivenhoven, Bart van de Sluis, Marten H Hofker, Debby P Y Koonen
Published 2014-01-01